Total planned funding: $126,404,220
Allocations
Countries/Regions
Ukraine | $126,404,220 |
Organizational Types
Unknown | $40,918,021 |
Private Contractor | $28,728,578 |
NGO | $16,082,328 |
Own Agency | $13,682,973 |
Multi-lateral Agency | $11,288,586 |
University | $4,717,000 |
Other USG Agency | $4,711,694 |
Implementing Agency | $4,425,040 |
Host Country Government Agency | $1,850,000 |
Program Areas
Governance and Systems | $55,594,083 |
Treatment | $22,528,502 |
Prevention | $18,096,151 |
Management and Operations | $10,273,151 |
Care | $10,246,508 |
Testing | $9,665,825 |
Budget Codes
OHSS: Health Systems Strengthening | $29,740,407 |
HVSI: Strategic Information | $14,318,201 |
HLAB: Laboratory Infrastructure | $11,535,475 |
HTXD: Treatment: ARV Drugs | $11,431,114 |
HTXS: Treatment: Adult Treatment | $11,097,388 |
HVMS: Management and Operations | $10,273,151 |
HVCT: Testing: HIV Testing and Counseling | $9,665,825 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $9,253,306 |
HVTB: Care: TB/HIV | $6,096,766 |
HVOP: Sexual Prevention: Other Sexual Prevention | $5,300,970 |
HMBL: Biomedical Prevention: Blood Safety | $2,851,624 |
HKID: Care: Orphans and Vulnerable Children | $2,460,190 |
HBHC: Care: Adult Care and Support | $1,689,552 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $293,357 |
HMIN: Biomedical Prevention: Injection Safety | $250,000 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $146,894 |
Top Partner Programs
Not Available:
$40,918,021
Countries/Regions
Chemonics International:
$16,839,470
Countries/Regions
USG Aggregated Agencies:
$12,867,973
Countries/Regions
Deloitte Consulting Limited:
$10,239,108
Countries/Regions